Improving HIV prevention and treatment for adolescents and young adults
Children's National Hospital Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
This study is all about helping young people aged 13-24 who are living with HIV by offering better prevention and treatment services, including easy access to counseling and medication, to improve their health and reduce the spread of HIV and other infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Westat, INC. NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-10880576 on NIH RePORTER |
What this research studies
This research focuses on enhancing HIV prevention and treatment services for adolescents and young adults aged 13-24 years living with HIV. It aims to provide comprehensive care through universal HIV counseling and opt-out screening, reaching out to thousands of young individuals in the District of Columbia and surrounding areas. The program includes pre-exposure prophylaxis and antiretroviral treatment for those already in care, with a strong emphasis on collaboration within scientific networks to improve health outcomes. By addressing the unique challenges faced by this age group, the research seeks to reduce the incidence of HIV and sexually transmitted infections.
Who could benefit from this research
Good fit: Ideal candidates for participation are adolescents and young adults aged 13-24 years who are at risk for or living with HIV.
Not a fit: Patients outside the age range of 13-24 years or those not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and reduced HIV transmission rates among adolescents and young adults.
How similar studies have performed: Previous research has shown success in improving HIV outcomes through targeted interventions for adolescents and young adults, indicating that this approach is promising.
Where this research is happening
Rockville, United States
- Westat, INC. — Rockville, United States (Active)
Researchers
- Principal investigator: Rakhmanina, Natella Yurievna — Westat, INC.
- Study coordinator: Rakhmanina, Natella Yurievna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.